The Pediatric Risk of Mortality Score: Update 2015

Murray M Pollack1, Richard Holubkov, Tomohiko Funai

  • 11Department of Pediatrics, Children's National Medical Center and the George Washington University School of Medicine and Health Sciences, Washington DC. 2Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT. 3Department of Pediatrics, Children's National Medical Center, Washington DC. 4Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI. 5Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. 6Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, CA. 7Department of Pediatrics, University of California at Los Angeles, Los Angeles, CA. 8Department of Critical Care Medicine, Children's Hospital of Pittsburgh, Pittsburgh, PA. 9Department of Child Health, Phoenix Children's Hospital and University of Arizona College of Medicine-Phoenix, Phoenix, AZ. 10Department of Pediatrics, University of Michigan, Ann Arbor, MI. 11Pediatric Trauma and Critical Illness Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institutes of Health (NIH), Bethesda, MD.

Insights

The updated Pediatric Risk of Mortality (PRISM) IV score improves accuracy in predicting pediatric intensive care unit (PICU) survival. New data collection methods reduce bias and errors for better patient risk assessment.

Area of Science:

  • Pediatric Critical Care Medicine
  • Health Services Research
  • Biostatistics

Background:

  • Severity of illness measures are crucial in pediatric critical care.
  • The Pediatric Risk of Mortality (PRISM) score quantifies physiologic status and predicts mortality/morbidity risk.
  • Previous PRISM versions required updates to reflect current practice and improve data accuracy.

Purpose of the Study:

  • To incorporate data collection improvements into the PRISM score.
  • To assess the performance of PRISM physiologic variable subcategories.
  • To recalibrate the PRISM score as PRISM IV and release the algorithms publicly.

Main Methods:

  • Prospective cohort study (December 2011 - April 2013) of 10,078 admissions.
  • Data divided into derivation (75%) and validation (25%) sets.
  • PRISM IV algorithm includes neurologic/nonneurologic scores, age, admission source, pre-admission arrest, cancer, and primary dysfunction systems.

Main Results:

  • Unadjusted mortality rate was 2.7%.
  • PRISM IV demonstrated excellent prediction performance with areas under the receiver operating characteristic curve of 0.88 ± 0.013 (development) and 0.90 ± 0.018 (validation).
  • Hosmer-Lemeshow statistics confirmed adequate model fit for both sets.

Conclusions:

  • New PRISM data collection methods significantly minimize bias and errors.
  • The PRISM IV algorithm shows excellent prediction performance for pediatric intensive care unit survival and death.
  • PRISM IV offers an improved tool for risk stratification in pediatric critical care.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
769
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
464
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
332
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732